The evolving role of coronary CT angiography in Acute Coronary Syndromes.
Cardiac computed tomography
Coronary artery disease
Heart attack
Non-ST-Segment elevation myocardial infarction
Journal
Journal of cardiovascular computed tomography
ISSN: 1876-861X
Titre abrégé: J Cardiovasc Comput Tomogr
Pays: United States
ID NLM: 101308347
Informations de publication
Date de publication:
Historique:
received:
08
11
2020
revised:
01
02
2021
accepted:
14
02
2021
pubmed:
17
4
2021
medline:
15
12
2021
entrez:
16
4
2021
Statut:
ppublish
Résumé
In the United States, non-obstructive coronary disease has been on the rise, and each year, nearly one million adults suffer myocardial infarction, 70% of which are non-ST-segment elevation myocardial infarction (NSTEMI). In addition, approximately 15% of patients suffering NSTEMI will have subsequent readmission for a recurrent acute coronary syndrome (ACS). While invasive angiography remains the standard of care in the diagnostic and therapeutic approach to these patients, these methods have limitations that include procedural complications, uncertain specificity in diagnosis of the culprit lesion in patients with multi-vessel coronary artery disease (CAD), and challenges in following coronary disease over time. The role of coronary computed tomography angiography (CCTA) for evaluating patients with both stable and acute chest pain has seen a paramount upshift in the last decade. This paper reviews the established role of CCTA for the rapid exclusion of obstructive plaque in troponin negative acute chest pain, while exploring opportunities to address challenges in the current approach to evaluating NSTEMI.
Identifiants
pubmed: 33858808
pii: S1934-5925(21)00026-5
doi: 10.1016/j.jcct.2021.02.002
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
384-393Informations de copyright
Copyright © 2021 Society of Cardiovascular Computed Tomography. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest Drs. Choi, and Earls report equity in Cleerly, Inc. Dr. Choi reports grant support from the GW Heart and Vascular Institute. All other authors report no relevant disclosures.